Zansulin 70/30

Zansulin 70/30 is a fixed ratio premix insulin formulation designed to improve glycemic control in adult patients with diabetes mellitus. This insulin is a combination of 70% isophane suspension and 30% regular insulin, providing both intermediate and fast-acting effects. It is indicated for subcutaneous use and should be administered in the abdominal wall, thigh, upper arm, or buttocks.

Each milliliter of Zansulin 70/30 contains 100 units of insulin, along with other ingredients like protamine sulfate, glycerin, dibasic sodium phosphate, metacresol, phenol, and zinc oxide. The pH of the suspension is between 7.0 and 7.8, and it is a sterile white suspension.

Individuals should use Zansulin 70/30 only as prescribed by their healthcare provider and adjust the dosage based on their metabolic needs, blood glucose monitoring results, and glycemic control goals. It is essential to follow the recommended dosing instructions to ensure effective management of diabetes.

Zansulin 70/30 is a reliable option for those seeking to manage their blood sugar levels effectively. Its unique blend of insulins helps in maintaining a balance between the rapid onset of action and the sustained effect, making it a valuable tool in diabetes management.